A detailed history of Creative Planning transactions in Alphatec Holdings, Inc. stock. As of the latest transaction made, Creative Planning holds 48,611 shares of ATEC stock, worth $484,651. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,611
Previous 26,440 83.85%
Holding current value
$484,651
Previous $276,000 2.17%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$5.45 - $11.87 $120,831 - $263,169
22,171 Added 83.85%
48,611 $270,000
Q2 2024

Aug 15, 2024

BUY
$9.49 - $14.26 $132,926 - $199,739
14,007 Added 112.66%
26,440 $276,000
Q1 2024

May 10, 2024

BUY
$12.8 - $16.78 $12,902 - $16,914
1,008 Added 8.82%
12,433 $171,000
Q4 2023

Feb 14, 2024

SELL
$8.89 - $15.36 $107,391 - $185,548
-12,080 Reduced 51.39%
11,425 $172,000
Q3 2023

Nov 16, 2023

BUY
$12.4 - $18.8 $291,462 - $441,894
23,505 New
23,505 $304,000
Q4 2022

Feb 10, 2023

BUY
$8.91 - $12.35 $1,042 - $1,444
117 Added 1.03%
11,464 $141,000
Q3 2022

Nov 03, 2022

SELL
$6.57 - $9.74 $611 - $905
-93 Reduced 0.81%
11,347 $99,000
Q2 2022

Aug 15, 2022

BUY
$6.36 - $13.08 $2,798 - $5,755
440 Added 4.0%
11,440 $75,000
Q1 2022

May 16, 2022

BUY
$9.45 - $12.85 $103,949 - $141,350
11,000 New
11,000 $127,000
Q4 2020

Jan 29, 2021

SELL
$6.37 - $14.52 $236,327 - $538,692
-37,100 Closed
0 $0
Q3 2020

Nov 05, 2020

SELL
$4.43 - $6.94 $13,821 - $21,652
-3,120 Reduced 7.76%
37,100 $246,000
Q2 2020

Jul 23, 2020

BUY
$3.05 - $5.59 $122,671 - $224,829
40,220 New
40,220 $189,000

Others Institutions Holding ATEC

About Alphatec Holdings, Inc.


  • Ticker ATEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 104,656,000
  • Market Cap $1.04B
  • Description
  • Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedic...
More about ATEC
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.